Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C8 | P10632 | 6/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2369871 | 0.90 | CYP3A4 (0.58) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL1918883 | 0.88 | CYP2C8 (0.68) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL2370074 | 0.87 | CYP2C8 (0.62) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL2369823 | 0.87 | CYP2C8 (0.47) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL2370889 | 0.87 | CYP2C8 (0.61) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL2369880 | 0.87 | CYP2C8 (0.60) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL2369562 | 0.86 | CYP2C8 (0.62) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL2369863 | 0.86 | CYP2C8 (0.60) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL2369921 | 0.86 | CYP2C8 (0.60) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 | |
| SCHEMBL2370375 | 0.85 | CYP2C8 (0.60) | CYP2C8KCNH2CYP3A4NR1I2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2545042-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | Bristol-Myers Squibb Company (US) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011112191-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-09-15 | — | — | WO | disclosed |